Priority Date: 11.10.11 (EP 20110306316)

EXON SKIPPING THERAPY FOR DYSTROPHIC EPIDERMOLYSIS BULLOSA

  • Application ID: EP12772927
  • Status: GRANT OF PATENT INTENDED

Attorney

Company dna nony
no operation time available
968.35
1 office
active in Legal Services

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB and 173 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 11.10.2011 - Priority Date (EP 20110306316)
  • 18.04.2013 - Publication A1 (WO2013053819)
  • 20.08.2014 - Publication A1 (EP2766480)

IPC Classification